A Tale from the Dusty Corner: Fulcrum Therapeutics Inc (FULC) Stock
RBC Capital Mkts raised the price target for the Fulcrum Therapeutics Inc (NASDAQ:FULC) stock to “an Outperform”. The rating was released on March 13, 2024, according to finviz. The research report from H.C. Wainwright has upgraded the stock from Neutral to Buy, with a price target set at $14. The stock was upgraded by Stifel, […]
Does Fulcrum Therapeutics Inc (FULC) Stock Really Excited You?
RBC Capital Mkts raised the price target for the Fulcrum Therapeutics Inc (NASDAQ:FULC) stock to “an Outperform”. The rating was released on March 13, 2024, according to finviz. The research report from H.C. Wainwright has upgraded the stock from Neutral to Buy, with a price target set at $14. The stock was upgraded by Stifel, […]
Fulcrum Therapeutics Inc (FULC) Stock at a key inflection point
RBC Capital Mkts raised the price target for the Fulcrum Therapeutics Inc (NASDAQ:FULC) stock to “an Outperform”. The rating was released on March 13, 2024, according to finviz. The research report from H.C. Wainwright has upgraded the stock from Neutral to Buy, with a price target set at $14. The stock was upgraded by Stifel, […]
Faced with a depressed economy, Fulcrum Therapeutics Inc (FULC) Stock offers an opportunity
RBC Capital Mkts raised the price target for the Fulcrum Therapeutics Inc (NASDAQ:FULC) stock to “an Outperform”. The rating was released on March 13, 2024, according to finviz. The research report from H.C. Wainwright has upgraded the stock from Neutral to Buy, with a price target set at $14. The stock was upgraded by Stifel, […]
Where are Investors’ Sentiments? Fulcrum Therapeutics Inc (FULC) Stock
RBC Capital Mkts raised the price target for the Fulcrum Therapeutics Inc (NASDAQ:FULC) stock to “an Outperform”. The rating was released on March 13, 2024, according to finviz. The research report from H.C. Wainwright has upgraded the stock from Neutral to Buy, with a price target set at $14. The stock was upgraded by Stifel, […]
